TRF2, a telomeric protein, declines with age and becomes further reduced after ischemic stress. Restoring TRF2 expression recovers cardioprotective signaling in aged hearts by enhancing mitophagy and suppressing inflammatory pathways, suggesting a mechanism underlying reduced resilience to ischemia-reperfusion injury in older patients.
Key Points
- TRF2 expression naturally declines with age in cardiac tissue
- TRF2 restoration improves heart recovery after ischemia-reperfusion injury
- TRF2 works via mitophagy enhancement and inflammatory pathway suppression
Longevity Analysis
This research identifies a specific molecular mechanism linking cellular aging to reduced cardiac resilience — a critical distinction because it points not to inevitable decline but to a recoverable signaling deficit. The pathway involves mitochondrial quality control and immune regulation, both hallmarks of systems that deteriorate with age but remain responsive to intervention. For practitioners, this suggests that age-related reduction in cardioprotective capacity is not a fixed loss but a reversible shift in protein expression and localization. The findings open a window on how the heart's defense and energy systems become dysregulated during aging, and how restoring a single regulatory protein can restore protection against one of the most common forms of tissue injury in older populations.
Original published by Wiley Aging Cell, by Xuan Zhang, Ji Ma, Ruichen Shu, Yuan Li, Ying Zheng, Yiqing Yin .